Skip to main content
SpringerLink
Log in

Ipriflavone: New insights into its mechanisms of action on bone remodeling

  • Letters to the Editor
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bonucci E, Ballanti P, Martelli A, Mereto E, Brambilla G, Bianco P, Bufalino L (1992) Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int 50:314–319

    Google Scholar 

  2. Tsuda M, Kitazaki T, Ito T, Fujita T (1987) The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1:207–211

    Google Scholar 

  3. Yamazaki I, Shino A, Shimizu Y, Tsukuda R, Shirakawa Y, Kinoshita M (1986) Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci 38:951–958

    Google Scholar 

  4. Yamazaki I, Shino A, Tsukuda R (1986) Effect of ipriflavone on osteoporosis induced by ovariectomy in rats. J Bone Miner Metab 3:205–210

    Google Scholar 

  5. Shino A, Matsuo T, Tsuda M, Yamazaki I, Tsukuda R, Kitazaki T, Shiota K, Okada H, Yoshida K (1986) Effect of ipriflavone on bone and mineral metabolism in the streptozotocin diabetic rats. J Bone Miner Metab 3:27–37

    Google Scholar 

  6. Fujita T, Ono K, Inoue T, Torizuka K, Shimazu A (1985) Dose finding study on TC-80 (ipriflavone) in osteoporosis. Prog Med 5:2959–2963

    Google Scholar 

  7. Orimo H, Nakai R, Itoh H, Shiraki M (1985) Effectiveness and safety of TC-80 for osteoporosis. Preliminary double-blind trial. Prog Med 5:2943–2949

    Google Scholar 

  8. Agnusdei D, Zacchei F, Bigazzi S, Cepollaro C, Nardi P, Montagnani M, Gennari C (1989) Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis. Drugs Exp Clin Res XV:97–104

    Google Scholar 

  9. Agnusdei D, Camporeale A, Zacchei F, Gennari C, Baroni MC, Costi D, Biondi M, Passeri M, Ciacca A, Sbrenna C, Falsettini E, Ventura A (1992) Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr Ther Res 52:81–92

    Google Scholar 

  10. Agnusdei D, Adami S, Cervetti R, Crepaldi G, Di Munno O, Fantasia L, Isaia GC, Letizia G, Ortolani S, Passeri M, Serni U, Vecchiet L, Gennari C (1992) Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Miner 19:543–548

    Google Scholar 

  11. Sziklai I, Ribari O (1985) The effect of flavone treatment on human otosclerotic ossicle organ cultures. Arch Otorhinolaryngol 242:67–70

    Google Scholar 

  12. Ribari O, Sziklai I (1987) Effect of flavonoid on PGE2-induced alterations in percentage collagen synthesis in ossicle organ cultures. Acta Otolaryngol 103:675–660

    Google Scholar 

  13. Benvenuti S, Tanini A, Frediani U, Bianchi S, Masi L, Casano R, Bufalino L, Serio M, Brandi ML (1991) Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J Bone Miner Res 6:987–996

    Google Scholar 

  14. Burger EH, van Der Meer JWM, Nijweide PJ (1984) Osteoclast formation from mononuclear phagocytes: role of bone-forming cells. J Cell Biol 99:1901–1906

    Google Scholar 

  15. McSheehy PMJ, Chambers TJ (1986) Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119: 1654–1659

    Google Scholar 

References

  1. Bonucci E, Ballanti P, Martelli A, Mereto E, Brambilla G, Bianco P, Bufalino L (1992) Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int 50:314–319

    Google Scholar 

  2. Bonucci E, Silvestrini G, Ballanti P, Masi L, Franchi A, Brandi ML (1992) Cytological and ultrastructural investigation of osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone. Preliminary results. Bone Miner 19(suppl):S15-S25

    Google Scholar 

  3. Wong GL (1986) Skeletal effects of parathyroid hormone. In: Peck WA (ed) Bone and mineral Research/4. Elsevier Science Publishers, Amsterdam, p 103

    Google Scholar 

  4. Marks SC Jr, Popoff SN (1988) Bone cell biology: the regulation of development, structure, and function in the skeleton. Am J Anat 183:1–44

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Unit Department of Clinical Physiopathology, University of Florence Medical School, Viale Pieraccini 6, 50139, Florence, Italy

    Maria Luisa Brandi

  2. Institute of Clinical Methodology, University of Siena Medical School, Piazza Duomo 2, 53100, Siena, Italy

    Carlo Gennari

  3. Section of Pathological Anatomy Department of Human Biopathology, University “La Sapienza”, Rome, Italy

    Ermanno Bonucci

Authors
  1. Maria Luisa Brandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Gennari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ermanno Bonucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandi, M.L., Gennari, C. & Bonucci, E. Ipriflavone: New insights into its mechanisms of action on bone remodeling. Calcif Tissue Int 52, 151–152 (1993). https://doi.org/10.1007/BF00308326

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00308326

Keywords

Search

Navigation